Skip to main content
Skip to footer

Vijaya Kumar

Senior Domain Consultant and a Subject Matter Expert with Regulatory CMC (Chemistry, Manufacturing, and Controls), TCS

Regulatory intelligence is imperative for the pharma industry of the future

Intelligent automation is now an inseparable part of several business functions. From reducing costs to simplifying data gathering between different systems, automation presents numerous opportunities to enhance quality and efficiency.

Advanced technologies such as artificial intelligence (AI), machine learning and natural language processing take over manual, repetitive, and time-consuming tasks to achieve self-evolving, automated systems with rapid outcomes. In a survey to identify potential development paths for these technologies, twenty of the twenty-two participating pharmaceutical companies stated that AI offers significant opportunities for Regulatory Intelligence (RI) activities in data processing (mining, searching, monitoring, alerting).Technology presents an opportunity to enhance the quality, speed, and efficiency of RI activities.

async> View My Stats